PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 5 days 19 hours 51 minutes
Emerging ‘Tumour-Agnostic’ Oncology Treatment: The Role of the Pathologist in Identifying Neurotrophic Tyrosine Kinase Gene Fusions
Visit https://www.peervoice.com/VMX860 to view the entire programme with slides.
Merging Clinical Trial Results and Reality: The Real-World Implications of Androgen Receptor Antagonists for Non–Metastatic Castration-Resistant Prostate Cancer
Visit https://www.peervoice.com/VNN860 to view the entire programme with slides.
Optimising Outcomes for Young Women With Breast Cancer: The Role of Adjuvant Ovarian Suppression
Visit https://www.peervoice.com/KKW860 to view the entire programme with slides.
Is There a Cardio-Oncologist in the House? Managing Risk for VTE and Stroke Due to AF in Patients With Cancer
Visit https://www.peervoice.com/UGZ860 to view the entire programme with slides.
Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy
Biomarkers in Lung Cancer: Targeting the Right Patient With the Right Therapy
Paroxysmal Nocturnal Haemoglobinuria: Complementing Current Knowledge To Improve Outcomes
Visit https://www.peervoice.com/ZDZ860 to view the entire programme with slides.
Best Practices for Use of Proteasome Inhibitors in the Treatment of Relapsed/Refractory Multiple Myeloma
Visit https://www.peervoice.com/MSX860 to view the entire programme with slides.
Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer
Clinical Updates: New Pathways and Strategies in Small-Cell Lung Cancer